rifampin

Drug ingredientActive Shortage

This drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.

Molecular structure of 13292-46-1

Where It Comes From

24 FDA-registered drug labelers
A-S Medication Solutions
American Health Packaging
Asclemed USA, Inc.
Bryant Ranch Prepack
Chartwell RX, LLC
CKD BIO Corp. Ansan Factory
CKD Bio Corporation
Coupler LLC
DARMERICA, LLC
EPIC PHARMA, LLC
EUROAPI Italy SRL
Fresenius Kabi USA, LLC
Hikma Pharmaceuticals USA Inc.
Kalchem International inc
Luohe Chief Pharmaceutical Co., Ltd.
LUPIN LIMITED
Lupin Pharmaceuticals, Inc.
Major Pharmaceuticals
MEDISCA Inc.
Mylan Institutional LLC
OLON ACTIVE PHARMACEUTICAL INGREDIENTS INDIA PRIVATE LIMITED
Olon SpA
PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS
Sanofi-Aventis U.S. LLC

Why It Matters

Sectors
Health
Downstream Uses

Appears in 2 drug and cosmetic product listings (FDA).

  • Rifampin
  • Rifadin IV
FDA Shortage Status
Active Shortage
Shortage History
to be discontinued

Rifampin Injection

04/20/2026

current

Rifampin Capsule

12/22/2021

Unavailable

current

Rifampin Injection

02/17/2021

Available

current

Rifampin Capsule

12/22/2021

Limited Availability

current

Rifampin Injection

02/17/2021

Unavailable

current

Rifampin Capsule

12/22/2021

Available

Chemical Identity

CAS13292-46-1
PubChem CID135398735
DTXSIDDTXSID6021244
FormulaC43H58N4O12
Mol. Weight822.9 g/mol
SMILESCC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C)C

Data Sources

1353987352026-04-07

https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/rifampin/cids/JSON

Archive: data/sources/pubchem_name/rifampin.json

CAS 13292-46-12026-04-25

https://open.fda.gov/data/ndc/

Archive: data/sources/fda/ndc/ndc.json

CAS 13292-46-12026-06-13

https://api.fda.gov/drug/shortages.json

Archive: data/sources/fda/shortages/shortages.json